Indu Drugs Private Limited, a active private limited company, was established on 04 April 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85191TG2012PTC080169. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.40 Cr and a paid-up capital of ₹4.39 Cr.
It upholds a compliant status. Employing 64 professional, Its leadership includes Sai Kumar Talasila (Whole-Time Director), Venkateswara Rao Talasila (Whole-Time Director), Talasila Hari Prasada Rao (Managing Director). Past directors included Rajeswari Talasila, Sai Kumar Talasila, Venkateswara Rao Talasila. It holds ₹4.00 Cr open charges and ₹2.90 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5-5-35/278 & 279, Prashanthi Nagar Ida, Kukatpally, Hyderabad, Telangana, 500072.
U85191TG2012PTC080169
080169
04 April 2012
₹4.40 Cr
₹4.39 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Indu Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sai Kumar Talasila | Whole-Time Director | 23 Nov 2016 | Current |
| Venkateswara Rao Talasila | Whole-Time Director | 09 Nov 2013 | Current |
| Talasila Hari Prasada Rao | Managing Director | 04 Apr 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2018 | Past |
| Pramod Abcsdd | Director | 01 Apr 2018 | Past |
| Pramod Abcsdd | Director | 01 Apr 2018 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2018 | Past |
| Pramod Abcsdd | Director | 09 Apr 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indu Drugs Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 42.44% increase. The company also saw a substantial improvement in profitability, with a 121.71% increase in profit. The company's net worth moved up by a moderate rise of 5.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Indu Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹40,000,000.00
₹29,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2023 | Hdfc Bank Limited | ₹4.00 Cr | Open |
| 26 Dec 2018 | Axis Bank Limited | ₹5.00 M | Satisfied |
| 01 Oct 2015 | Canara Bank | ₹1.40 Cr | Satisfied |
| 05 Dec 2012 | State Bank Of India | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Indu Drugs has a workforce of 64 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indu Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Indu Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Indu Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 4.00 Cr registered on 15 Jul 2023 with Charge ID 100753475 was modified on 18 Jul 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 4.00 Cr with Charge ID 100753475 was registered on 15 Jul 2023. was recorded as a recent event.
The activity A charge registered on 01 Oct 2015 via Charge ID 10595585 with Canara Bank was fully satisfied on 18 Mar 2023. was completed.
A charge registered on 26 Dec 2018 via Charge ID 100243343 with Axis Bank Limited was fully satisfied on 21 Jan 2022. was recorded as a recent event.
The CIN of Indu Drugs Private Limited is U85191TG2012PTC080169.
Indu Drugs Private Limited is headquartered at 5-5-35/278 & 279, Prashanthi Nagar Ida, Kukatpally, Hyderabad, Telangana, 500072.
Indu Drugs Private Limited was incorporated on 04 April 2012.
The current directors of Indu Drugs Private Limited are
The primary industry of Indu Drugs Private Limited is Manufacturing.
Indu Drugs Private Limited is unlisted.
The authorized capital of Indu Drugs Private Limited is ₹4.40 Cr, and the paid-up capital is ₹4.39 Cr.
The compliance status of Indu Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX